ADC Therapeutics SA Profit Margin 2019-2022 | ADCT
Current and historical gross margin, operating margin and net profit margin for ADC Therapeutics SA (ADCT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ADC Therapeutics SA net profit margin as of December 31, 2022 is -74.22%.
| ADC Therapeutics SA Annual Profit Margins |
| ADC Therapeutics SA Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.153B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
